Patients on end-of-life care are usually just making themselves comfortable, but Stacy W. was doing exactly the opposite. Unwilling to give up on her life, Stacy continued to pursue a natural path towards healing. It wasn’t long before she was kicked off hospice and told her cancer was completely gone. Learn how Stacy went from […]
Continue readingThe United States has certainly come a long way in the last few decades in its ability to successfully treat cancer. Yet still, so many people have died from the disease, creating a growing frustration over the lack of treatment options. Many standard of care protocols have been the same for over 30 years, with […]
Continue readingThe U.S. Food and Drug Administration (FDA) currently has several ongoing trials testing immunotherapy cancer treatments like CPG and checkpoint inhibitor drugs. In fact, the internet was up in arms last year when Stanford University doctors cured 87 out of 90 mice with a “vaccine” that stimulated the immune system to attack cancerous cells. It […]
Continue readingThe history of CHIPSA Hospital is in a way, the history of Gerson Therapy itself. We are known as the Gerson Therapy hospital because our hospital was founded by Charlotte Gerson, the daughter of Max Gerson, the man who created the Gerson Immuno-Nutrition Protocol. The hospital that is now CHIPSA began using the Gerson Protocols […]
Continue readingJohn D. was diagnosed with stage 4 squamous cell and basal cell carcinoma in his neck over three years ago. Last year, John had developed a fluid-filled sac on his neck that began to change, harden, and grow. The growth eventually spread throughout his throat all the way to the other side of his neck. Having […]
Continue readingRussell W. was given 6 months to live back in 2018 after his non-Hodgkin’s lymphoma spread to his skin. But now, nearly 14 months later, he is alive, well, and eager to share his story. Russell’s journey began when he noticed a swollen lymph node near his elbow back in 2016. […]
Continue readingA recent report in the journal Cell showed that a team led by Vanderbilt researchers has found a new “checkpoint” protein on immune system cells in active, malignant tumors. In mouse models, blocking this protein, along with using other treatments, has been an effective approach to treating cancerous cells. Checkpoint proteins are an important component of […]
Continue readingA recent study published in Nature Genetics called “Tumor mutational load predicts survival after immunotherapy across multiple cancer types” revealed that tumors with more mutations had better results with immunotherapy treatment. The study looked at data from 1,662 metastatic cancer patients who received checkpoint inhibitor therapy, and data from over 5,000 patients who were not treated […]
Continue readingA research team from the University of Maryland is utilizing artificial intelligence (AI) to determine the most effective ways to treat cancer patients with immunotherapy. Immunotherapy takes advantage of the body’s own immune system to fight off cancer, and in the past decade, it has been very successful in treating patients with localized and advanced […]
Continue readingThe ORIENT-15 Phase 3 clinical trial evaluating Tyvyt (sintilimab injection) combined with chemotherapies Taxol (paclitaxel) and Platinol (cisplatin) as treatment for esophageal squamous cell carcinoma is now underway. Tyvyt was developed by Innovent Biologics and Eli Lilly and Company in China as an immune checkpoint inhibitor that will work against PD-1, a protein found on […]
Continue reading